University of Kentucky

UKnowledge
Radiology Faculty Publications

Radiology

7-2-2021

Primary Bilateral Ovarian Artery Embolization for Uterine
Leiomyomatosis in the Setting of a Rare Anatomic Variant Hypoplastic Uterine Arteries
Merve Ozen
University of Kentucky, moz226@uky.edu

Shezaan Momin
Texas Tech University

Charles Ben Myers
University of Kentucky, Ben.Myers@uky.edu

Mark Hoffman
University of Kentucky, mark.hoffman@uky.edu

Driss Raissi
University of Kentucky, driss.raissi@uky.edu

Follow this and additional works at: https://uknowledge.uky.edu/radiology_facpub
Part of the Obstetrics and Gynecology Commons, and the Radiology Commons

Right click to open a feedback form in a new tab to let us know how this document benefits you.
Repository Citation
Ozen, Merve; Momin, Shezaan; Myers, Charles Ben; Hoffman, Mark; and Raissi, Driss, "Primary Bilateral
Ovarian Artery Embolization for Uterine Leiomyomatosis in the Setting of a Rare Anatomic Variant Hypoplastic Uterine Arteries" (2021). Radiology Faculty Publications. 37.
https://uknowledge.uky.edu/radiology_facpub/37

This Article is brought to you for free and open access by the Radiology at UKnowledge. It has been accepted for
inclusion in Radiology Faculty Publications by an authorized administrator of UKnowledge. For more information,
please contact UKnowledge@lsv.uky.edu.

Primary Bilateral Ovarian Artery Embolization for Uterine Leiomyomatosis in the
Setting of a Rare Anatomic Variant - Hypoplastic Uterine Arteries
Digital Object Identifier (DOI)
https://doi.org/10.1016/j.radcr.2021.05.069

Notes/Citation Information
Published in Radiology Case Reports, v. 16, issue 9.
© 2021 The Authors
This is an open access article under the CC BY-NC-ND license (https://creativecommons.org/licenses/bync-nd/4.0/).

This article is available at UKnowledge: https://uknowledge.uky.edu/radiology_facpub/37

Radiology Case Reports 16 (2021) 2426–2428

Available online at www.sciencedirect.com

journal homepage: www.elsevier.com/locate/radcr

Case Report

Primary bilateral ovarian artery embolization for
uterine leiomyomatosis in the setting of a rare
anatomic variant - hypoplastic uterine arteries ✩
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Article history:

We present the case of a 50-year-old female who underwent bilateral ovarian artery em-
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bolization for uterine fibroids in the setting of hypoplastic uterine arteries. Ovarian artery
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embolization is usually conducted during uterine artery embolization for fibroids to increase
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the procedure success when ovarian feeders are seen. The bilateral ovarian artery emboliza-
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tion is rarely performed due to fears of amenorrhea and early menopause from decreased
blood supply to both ovaries. According to our knowledge, this the first case report describ-
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hypoplastic uterine arteries. The patient had complete resolution of symptoms from her
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uterine fibroids after treatment with bilateral ovarian artery embolization with no ovarian
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failure findings on the follow-up.
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Introduction
Uterine artery embolization is an established therapy for the
management of symptomatic uterine fibroids. While the procedure reduces total leiomyoma volume and decreases or
eliminates clinical symptoms, the procedure’s failure rate
stands at 9.4% [[1]]. One cause of treatment failure is persistent

blood supply to the fibroid from utero-ovarian anastomosis
branches. Although various studies have described successful unilateral ovarian artery embolization for the treatment of
symptomatic uterine fibroids, to the best of our knowledge,
primary bilateral ovarian artery embolization (BOAE) in the
setting of hypoplastic uterine arteries has not been described
in the literature. In this report, we aim to illustrate the technical feasibility and outcome of a patient with the rare variant of hypoplastic uterine arteries treated with BOAE and for
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Fig. 1 – (A) Pre-embolization sagittal T1 weighted (W) Fat-Saturated (FS) post-contrast image through the pelvis demonstrates
numerous intramural (black arrows) and subserosal (white arrow) enhancing fibroids. (B) Post-embolization sagittal T1-W
FS post-contrast image through the pelvis demonstrates multiple intramural non-enhancing treated fibroids (black arrows).

symptomatic uterine fibroids. Case reports are exempt from
institutional review board approval at the originating institution.

demonstrated embolization material within blood vessels adjacent to a leiomyoma with ischemic-type necrosis consistent
with embolization (Fig. 3).

Case report

Discussion

A 50-year-old woman with a 16-year history of menorrhagia,
dysmenorrhea, and anemia secondary to uterine fibroids presented to our multidisciplinary fibroid clinic. Upon evaluating clinical and MRI (magnetic resonance imaging) findings
(Fig. 1A), we discussed medical, interventional, and surgical
options with the patient and the gynecologist, and a decision
was made to perform uterine fibroid embolization (UFE). Informed consent was obtained for the procedure. Initial pelvic
aortogram demonstrated bilateral hypertrophic ovarian arteries feeding the enlarged fibromatous uterus. Bilateral uterine
arteries were diminutive on the angiogram. (Fig. 2). Endovascular embolization of both ovarian arteries was performed
with 500 to 700 microns and 700 to 900 microns of Embosphere
microspheres (Merit Medical Systems, Inc, South Jordan, Utah)
using a 2.4-French Progreat microcatheter (Terumo Medical
Corporation, Somerset, New Jersey) through a 4-French (F)
Mickelson catheter (Cook, Inc, Bloomington, Indiana) until
near stasis.
At the six-week clinic follow-up, no early complications
were observed, and the patient was satisfied with the procedure. MRI was obtained as part of the six-month followup, which showed decreased uterine and fibroids size with no
residual fibroid enhancement (Fig. 1B). During the six-month
clinic visit, she reported having regular periods for three cycles with no pelvic pain and heavy bleeding. She denied ovarian failure symptoms. On the MRI, both ovaries revealed no
evidence of infarction. The pre-procedure hemoglobin level of
4.5 g/dL increased to 11.9 g/dL. At 9-months, she decided to
have a hysterectomy due to a fibroid expulsion and desire not
to have menstruations anymore. The gynecologist performed
total laparoscopic hysterectomy and salpingo-oophorectomy.
Histopathologic assessment of the post-surgical specimen

Bilateral OAE is rarely discussed in the literature to treat uterine fibroids with collateral supply from the ovarian artery. One
fear clinicians have in performing bilateral OAE is ovarian failure resulting from infarction. There is also conflicting literature with Razavi et al., concluding that ovarian artery embolization should only be performed unilaterally [2]. On the
contrary, a case series by Barth et al. noted that three patients
treated with bilateral OAE in addition to uterine artery embolization retained ovarian function after the procedure [3]. In
this report, bilateral OAE did not cause early menopause after
the procedure while still achieving complete clinical success.
There are two case reports in the literature describing bilateral hypoplastic/absent uterine artery variant which was
found during uterine artery embolization attempt. In these
cases, embolization was not performed due to fear of causing early menopause. In our case, we decided to perform the
embolization despite the rare variant anatomy due to patient
long history of anemia and initial decision to avoid hysterectomy [4].
From a technical standpoint, 500 to 700 microns and 700 to
900 microns Embospheres proved to be adequate in achieving near stasis of blood flow during bilateral ovarian artery
embolization. It was further confirmed after histologic staining, which showed embolization material within one of the
fibroids. Despite embolic material seen in the ovary on histology (Fig. 3B), the patient did not exhibit any ovarian failure
symptoms after the procedure. MRI and histopathology findings supported that both ovaries were still viable. One may deduce from this report that the same-sized Embospheres typically used for uterine artery embolizations can also be used in
bilateral ovarian artery embolizations. However, Verret et al.
reported that either 700 or 900-micron Embozene (CeloNova
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Fig. 2 – (A) Digital subtraction aortogram demonstrates enlarged tortuous ovarian arteries (white arrows) and hypoplastic
uterine arteries (black arrows). (B) Delayed phase image from digital subtraction aortogram shows opacification of the
fibromatous uterus (black arrows).

for bilateral ovarian artery embolization in selected patients.
Long term follow-up will be needed to establish long term
safety.
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Fig. 3 – (A) Histopathologic images of the embolized uterine
fibroid. Original magnification x4. Hematoxylin and eosin.
Embolization material (black arrows) within the arteries
adjacent to a leiomyoma with ischemic-type necrosis
(white arrow). (B) Original magnification x4. Hematoxylin
and eosin. Embolization material (arrows) within the hilum
of the ovary.
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